Last edition
News about "Drugmakers to Revise MRP"
NPPA Directs Drugmakers to Revise MRPs After 2026 Duty Exemptions
The National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturers to revise the maximum retail prices (MRP) of medicines that received customs duty exemptions under the Union Budget 2026.
Drugmakers To Revise MRP | 12/02/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members